CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
56.88
-1.30 (-2.23%)
At close: Dec 5, 2025, 4:00 PM EST
57.17
+0.29 (0.52%)
After-hours: Dec 5, 2025, 7:59 PM EST

CRISPR Therapeutics AG Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
286.5298.26389.48211.89923.031,169
Upgrade
Short-Term Investments
1,6291,6061,3041,6031,456521.71
Upgrade
Cash & Short-Term Investments
1,9161,9041,6941,8152,3791,690
Upgrade
Cash Growth
-1.03%12.41%-6.70%-23.70%40.75%79.10%
Upgrade
Accounts Receivable
-25200-0.310.14
Upgrade
Other Receivables
-2.16.511.28.410.7
Upgrade
Receivables
-27.1206.511.28.7110.84
Upgrade
Prepaid Expenses
9.886.217.8926.0129.6815.44
Upgrade
Restricted Cash
3.5--0.5--
Upgrade
Total Current Assets
1,9291,9371,9081,8532,4181,717
Upgrade
Property, Plant & Equipment
255.49277.55305.94320.56312.0493.03
Upgrade
Long-Term Investments
51.01-1.9753.13--
Upgrade
Other Intangible Assets
--0.020.070.130.18
Upgrade
Other Long-Term Assets
9.7127.3513.5716.2822.218.14
Upgrade
Total Assets
2,2452,2422,2302,2432,7521,828
Upgrade
Accounts Payable
11.814.7138.1527.4314.829.09
Upgrade
Accrued Expenses
24.939.4140.6761.3377.7754.32
Upgrade
Current Portion of Leases
18.2617.2915.6315.8412.1611.36
Upgrade
Current Income Taxes Payable
3.430.450.440.140.7210.47
Upgrade
Current Unearned Revenue
1.33.854.11-1.012.34
Upgrade
Other Current Liabilities
59.2812.089.8116.3813.46.67
Upgrade
Total Current Liabilities
118.9687.78108.79121.11119.8894.26
Upgrade
Long-Term Leases
192.77206.41223.01228.18212.8750.07
Upgrade
Long-Term Unearned Revenue
12.3212.3214.0112.3212.3211.78
Upgrade
Other Long-Term Liabilities
5.283.440.965.977.347.63
Upgrade
Total Liabilities
329.33309.95346.77367.58352.42163.73
Upgrade
Common Stock
3.012.72.52.442.392.28
Upgrade
Additional Paid-In Capital
3,7253,2942,8782,7352,5982,236
Upgrade
Retained Earnings
-1,817-1,366-999.7-846.09-195.92-573.58
Upgrade
Treasury Stock
-0.06-0.06-0.06-0.06-0.06-0.06
Upgrade
Comprehensive Income & Other
4.991.841.91-15.65-5.07-0.08
Upgrade
Total Common Equity
1,9161,9321,8831,8752,3991,664
Upgrade
Shareholders' Equity
1,9161,9321,8831,8752,3991,664
Upgrade
Total Liabilities & Equity
2,2452,2422,2302,2432,7521,828
Upgrade
Total Debt
211.02223.69238.63244.02225.0361.43
Upgrade
Net Cash (Debt)
1,7331,6801,4571,6242,1541,629
Upgrade
Net Cash Growth
1.46%15.31%-10.30%-24.59%32.24%82.77%
Upgrade
Net Cash Per Share
19.8219.9218.3920.8926.7924.70
Upgrade
Filing Date Shares Outstanding
95.385.7780.2878.6577.0775.43
Upgrade
Total Common Shares Outstanding
93.8785.7480.0478.5176.9973.91
Upgrade
Working Capital
1,8101,8491,7991,7322,2981,622
Upgrade
Book Value Per Share
20.4122.5323.5223.8931.1722.52
Upgrade
Tangible Book Value
1,9161,9321,8831,8752,3991,664
Upgrade
Tangible Book Value Per Share
20.4122.5323.5223.8931.1622.51
Upgrade
Machinery
54.854.453.2649.6236.2529.5
Upgrade
Construction In Progress
5.86.128.866.1652.48.37
Upgrade
Leasehold Improvements
145.85145.85143.26141.6886.7425.47
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.